Via Bloomberg
- Acceleron (XLRN) raised to buy at Citi
- Estee Lauder (EL) raised to overweight at Piper Jaffray, PT $95
- Exxon (XOM) raised to neutral at Credit Suisse
- Sarepta (SRPT) raised to outperform at Leerink, PT $47
- Seaspan (SSW) raised to neutral at JPMorgan, PT $8
- WSP Global (WSP CN) raised to buy at Desjardins, PT C$52
- Windstream (WIN) raised to hold at Jefferies, PT $7.50
- American Eagle (AEO) cut to neutral at BofAML, PT $15
- Apache (APA) cut to underweight at Barclays, PT $50
- Camping World Holdings (CWH) cut to sector weight at Keybanc
- Dycom Industries (DY) cut to neutral at DA Davidson
- Golden Ocean (GOGL) cut to buy at Swedbank, PT NOK67
- Idex (IEX) cut to neutral at Janney
- Kaman (KAMN) cut to neutral at Longbow
- Kite Pharma (KITE) cut to neutral at Citi
- RAIT Financial Trust (RAS) cut to hold at Deutsche Bank
- SunOpta (SOY CN) cut to hold at Wunderlich
- Time Warner (TWX) cut to hold at Loop Capital, PT $107.50
- TripAdvisor (TRIP) cut to neutral at Piper Jaffray, PT $47
- VimpelCom (VIP) cut to market perform at Renaissance Capital
- Acceleron (XLRN) rated new buy at Nomura
- Alexion (ALXN) rated new buy at Nomura
- Ameriprise (AMP) rated new outperform at William Blair
- Autoliv (ALV) rated new neutral at Mizuho, PT $115
- B2Gold (BTO CN) reinstated buy at BofAML, PT C$5.20
- Ball (BLL) rated new neutral at Goldman, PT $80
- BioMarin (BMRN) rated new neutral at Nomura
- Biogen (BIIB) rated new buy at Nomura, PT $345
- Celadon Group (CGI) rated new buy at Aegis, PT $15
- Cellectis (ALCLS FP) rated new buy at Nomura
- Cogent Comms (CCOI) rated new neutral at Goldman, PT $43
- CytomX (CTMX) rated new buy at Nomura
- DaVita (DVA) re-initiated market perform at Bernstein, PT $68.50
- Dalradian Resources (DNA CN) rated new buy at Eight Capital, PT C$1.70
- Five Prime (FPRX) rated new buy at Nomura
- Galapagos (GLPG NA) rated new buy at Nomura
- Global Blood (GBT) rated new buy at Nomura
- Incyte (INCY) rated new buy at Nomura
- Interpublic (IPG) rated new buy at BofAML, PT $28
- MacroGenics (MGNX) rated new buy at Nomura
- Mobileye (MBLY) rated new neutral at Mizuho, PT $50
- Nemaska Lithium (NMX CN) rated new outperform at National Bank
- Omnicom (OMC) rated new neutral at BofAML, PT $91
- PRA Group (PRAA) resumed overweight at First Analysis
- Parker-Hannifin (PH) resumed overweight at Morgan Stanley, PT $180
- Prothena (PRTA) rated new buy at Nomura
- Regency Centers (REG) resumed neutral at Citi
- Sarepta (SRPT) rated new buy at Nomura
- Shopify (SHOP CN) rated new outperform at National Bank, PT $80
- Splunk (SPLK) rated new outperform at Bernstein, PT $72
- Syndax Pharmaceuticals (SNDX) rated new buy at Nomura
- Voyager Therapeutics (VYGR) rated new buy at Nomura
- Xencor (XNCR) rated new neutral at Nomura
- Xilinx (XLNX) rated new neutral at Mizuho, PT $64
